Lca tool for sustainability evaluations in the pharmaceutical industry

Chemical Engineering Transactions

Volumn 26, Issue , 2012, Pages 261-266

  Mata, Teresa M ^a,d   Martins, António A ^b,d   Neto, Belmira ^c,d   Martins, Maria L ^d   Salcedo, Romualdo L R ^a   Costa, Carlos A V ^a  

^a LEPAE   (Portugal)

^b Center for Transport Phenomena Studies   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; SUSTAINABLE DEVELOPMENT;

ACTIVE PHARMACEUTICAL INGREDIENTS; GENETICALLY MODIFIED ORGANISMS; LIFE CYCLE ASSESSMENT (LCA); PHARMACEUTICAL INDUSTRY; PHARMACEUTICAL PRODUCTS; SUSTAINABILITY ASSESSMENT; SUSTAINABILITY EVALUATIONS; SUSTAINABILITY INDICATORS;

LIFE CYCLE;

EID: 84864460283     PISSN: 22839216     EISSN: 22839216     Source Type: Journal    
DOI: 10.3303/CET1226044     Document Type: Conference Paper

References (18)

1. Geibler J., Liedtke C., Wallbaum H., Schaller S., 2006, Accounting for the Social Dimension of Sustainability: Experiences from the Biotechnology Industry, Busin. Strat. Env., 15, 334-346. (Pubitemid 44501310)
2. ISO 14040, 2006, Environmental management, Life cycle assessment, Principles and framework, Geneva, Switzerland: Int Organisation for Standardisation; [ISO 14040].
3. Jimez-Gonzales C., Curzons A.D., Constable D.J.C., Cunningham V.L., 2004, Cradle-to-Gate Life Cycle Inventory and Assessment of Pharmaceutical Compounds, Int. J. LCA, 9, 114-121. (Pubitemid 38419606)
4. Jong A.M., 2003, Limited LCAs of Pharmaceutical Products: Merits and Limitations of an Environmental Management Tool, Corporate Social Responsibility and Environ. Manag., 10, 78,90.
5. Jornitz M.W., Meltzer T.H., 2007, Filtration and Purification in the Biopharmaceutical Industry. 2nd Edition, vol. 174, Informa HealthCare, New York/London, United States/United Kingdom, 2ed.
6. Kim S., Jimez-Gonzez C., Dale B.E., 2009, Enzymes for pharmaceutical applications-a cradle-togate life cycle assessment, Int. J. LCA, 14, 392-400.
7. Martins A.A., Mata T.M., Sikdar S., Costa C., 2007, A Framework for Sustainability Metrics, Ind. Eng. Chem. Res., 46, 2962-2973.
8. Mata T.M., Costa C.A.V., 2001, Life cycle assessment of different reuse percentages for glass beer bottles, Int. J. LCA, 6(5), 307-319. (Pubitemid 32916591)
9. Mata T.M., Martins A.A., Sikdar S., Costa C.A.V., 2011, Sustainability Considerations of Biodiesel Based on Supply Chain Analysis, Clean Technol. Environ. Policy, 13, 655-671.
10. Mata T.M., Smith R.L., Young D.M., Costa C.A.V., 2003, Life cycle assessment of gasoline blending options, Environ. Sci. Technol., 37(16): 3724-3732. (Pubitemid 36999319)
11. Mata, T.M., Smith, R.L., Young, D.M., Costa, C.A.V., 2005, Environmental analysis of gasoline blending components through their life cycle, J. Clean Prod., 13(5 Spec. Iss.), 517-523.
12. Morais S., Mata T.M., Ferreira E., 2010, Life cycle assessment of soybean biodiesel and LPG as automotive fuels in Portugal, Chemical Engineering Transactions 19, 267-272. DOI: 10.3303/CET1019044.
13. Parikh D.M., 2005, Handbook of Pharmaceutical Granulation Technology. Taylor & Francis Group, Boca Raton, Florida, United States, 2ed.
14. Ponder C., Overcash M., 2010, Cradle-to-gate life cycle inventory of vancomycin hydrochloride, Sci. Total Environ., 408, 1331-1337.
15. Smith R.L., 2010, Biofuel supply chains: Impacts, indicators and sustainability metrics, Chemical Engineering Transactions, 21, 1135-1140. DOI: 10.3303/CET1021190.
16. Veleva V., Hart M., Greiner T., Crumbley C., 2003, Indicators for measuring environmental sustainability: A case study of the pharmaceutical industry, Benchmarking: An International Journal, 10(2), 107-119.
17. Walsh G., 2003, Biopharmaceuticals Biochemistry and Biotechnology. Wiley & Sons, UK, 2ed.
18. Wernet G., Conradt S., Isenring H.P., Jimez-Gonzez C., Hungerbler K., 2010, Life cycle assessment of fine chemical production: a case study of pharmaceutical synthesis, Int. J. LCA, 15, 294-303.